LFCR (Lifecore Biomedical Inc.) Net earnings per share growth forecast for next year

lifecore.com (LFCR) - corporate logo

Reliance on the expertise of biochemists ensures that Lifecore Biomedical (LFCR) delivers high-quality order execution, as confirmed by the base chart on GURU.Markets. The consensus EPS forecast for the coming year via 0.00 reflects the current volume of this metric. Meanwhile, Lifecore Biomedical (LFCR) is implementing eco-friendly production methods, adhering to bioethics, and focusing on organic growth without new mergers following an internal audit.

Lifecore Biomedical Inc. (LFCR): Net earnings per share growth forecast for next year from 04/28/2023 to 11/11/2026

Lifecore Biomedical, Inc. (LFCR) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Stock Quotes Lifecore Biomedical Inc.|LFCR - Analyst Forecast Prices
- business market valuation indicators:
Market Value Lifecore Biomedical|LFCR - Company Buyout Price
- company book value details:
Net Assets per Single Share Lifecore Biomedical|LFCR - Company Book Value|Market Capitalization to Book Value Ratio lifecore.com|LFCR - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Lifecore Biomedical|LFCR - Long-Term Liabilities to Equity|Short-Term Debt to Capital Lifecore Biomedical Inc.|LFCR - Company Cumulative Debt|Debts to Book Capitalization Lifecore Biomedical|LFCR - Company Long-Term Liabilities|Company Short-Term Debt Lifecore Biomedical|Quick Liquidity lifecore.com
- net income and valuation ratios data:
LFCR - Final Profit|Projected Future Earnings Lifecore Biomedical|LFCR - Market Cap to Earnings|Projected Price to Earnings Lifecore Biomedical Inc.|LFCR - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Lifecore Biomedical|LFCR - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Lifecore Biomedical|LFCR - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months lifecore.com|LFCR - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Lifecore Biomedical
Fundamental company analysis:Lifecore Biomedical, LFCR
Finished products of Lifecore Biomedical, Inc.

Investors are assessing the risk of asset overvaluation by analyzing the gap between price and actual earnings growth rates. Rigorous FDA validation of Lifecore Biomedical (LFCR) processes creates high barrier inertia, guaranteeing the stability of long-term contracts. The projected EPS growth rate measures the dynamics of Wall Street forecast revisions regarding future earnings per share. A sharp spike in this indicator often signals the formation of a bubble, warning of the risk of entering at the peak.

Analysis of competing companies

Expected earnings per share growth for next year IQV|LH (LabCorp) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Medpace Holdings, Inc. (MEDP)|Consensus forecast of earnings per share growth for next year ICON plc|Net earnings per share growth forecast for next year Charles River CRL|Evotec AG - Net earnings per share growth forecast for next year|Fortrea Corp - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year OmniAb Inc OABI|NOTV: Earnings growth forecast for next year|Net earnings per share change forecast for next year CDMO (avidbio.com)|CTLT (Catalent) - Earnings growth forecast for next year|Expected net earnings per share growth next year Scorpius Holdings Inc. SCPX